Developing Clinical Questions: Clinton Pong, MD Randi Sokol, MD, MPH
Developing Clinical Questions: Clinton Pong, MD Randi Sokol, MD, MPH
Developing Clinical Questions: Clinton Pong, MD Randi Sokol, MD, MPH
Clinton Pong, MD
Randi Sokol, MD, MPH
http://img.timeinc.net/time/daily/2007/0702/a_scevidence_0214.jpg
Introductory Case:
• A 45-year-old male with hypertension presents to your clinic
for follow up. At a prior visit he was screened for diabetes.
• His hemoglobin A1C has been 7.0% on two occasions, which is
a new diagnosis of diabetes.
• His blood pressure is well controlled at 125/80.
• He has no evidence of microalbuminuria or kidney disease.
• You recall from medical school that ACEi are good for
preventing diabetic kidney disease, but you’re not sure if this
fact applies to this patient.
Background Foreground
Questions Questions
General
EBM Resources Research
Basic Clinical
Background Studies
eg, Guidelines
To develop a
“Medical Student “Resident Questions” searchable
Questions” eg, appropriate steps in clinical query,
eg, etiology, pathophys, workup and management you need to formulate
pharmacology a foreground question
in the PICO format
(Based on BU and Dartmouth models)
The PICO Question Components
• Problem and Population
• What is the disease or condition?
P • What are the important characteristics of my
patient?
• Intervention
• What is the intervention I am looking for?
• Is it realistic (availability, cost, convenience, etc)?
I C • Is this different from how I currently practice?
• Comparison
• What is the alternative to the intervention?
• Outcome
O • Is it something patients care about?
• Or is it something only physiologists/pharmacists
care about?
(Jackson, 2006; Flaherty, 2004)
So, how do I develop a clinical
question?
Focusing the PICO question
• Population
• Starting with your patient, ask "How would I describe a group of
patients similar to mine?"
• Be precise but brief.
• Intervention/Comparison
• Ask “What is the main intervention I am considering?”
• and “What is the main comparison/control?”
• Be specific, but consider feasible alternatives.
• Outcomes
• Ask "What can I hope to accomplish?" or "What could this
exposure really affect?“
• Select patient-oriented outcomes instead of “the numbers.”
(University of Oxford EBM Tools, 2013)
Intro Case:
Foreground PICO Question Brainstorming
• Problem/Population
• “In adult patients with diabetes mellitus II and
P hypertension”
• Intervention
• “Does an ACEi”
• Comparison
I C • “Compared to placebo” or “BB/CCB/diuretic/etc.”
• Outcome
• “Prevent development of microalbumuria?”
OR
• “Prevent worsening of eGFR?”
O
Are these outcomes
our patient cares about?
The Patient Is What Matters
Disease-Oriented Patient-Oriented Evidence
Evidence (DOE) That Matters (POEMs)
• Measures outcomes • Measure outcomes
that are markers for that our patients care
disease about.
• “Silent • They have the
numbers” potential to change
the way we practice!
(Slawson , 1994)
Characteristics of DOEs and POEMs
Disease-Oriented Patient-Oriented Evidence
Evidence (DOE) That Matters (POEMs)
• Pathophysiology • Morbidity
• Lab values • Symptoms
• Biochemical markers • Daily function
• Pharmacology • Mortality
• Plaque size • Quality of Life
• Blood pressure • (as perceived by the
• Etiology patient)
(Slawson , 1994)
Examples of DOEs and POEMs
Disease-Oriented Patient-Oriented Evidence
Evidence (DOE) That Matters (POEMs)
Intensive treatment can Intensive treatment in patients
lower blood glucose levels with type II diabetes does not
in patients with type II decrease mortality.
diabetes
Neither beta-carotene or
Beta-carotene and vitamin vitamin E prevent
E are good antioxidants cardiovascular disease or
cancer
(Tufts, 2013)
Examples of DOEs and POEMs
Disease-Oriented Patient-Oriented Evidence
Evidence (DOE) that Matters (POEMs)
The drug varenicline can help Varenicline increases the risk
smokers stop smoking of cardiovascular events.
(which should lead to a decrease
in cardiovascular events).
O Is eGFR an outcome
our patient cares about?
Possible POEM Alternatives:
“In patients with diabetes, are ACEi associated with
lower mortality rates?”
Or
“In patients with diabetes, do ACEi delay
progression toward end-stage kidney disease
requiring dialysis?”
Or
“In patients with diabetes, do ACEi delay
progression toward end-stage kidney disease
requiring a kidney transplant?”
(Cochrane, Lv 2012)
Alternate Clinical Queries
• After developing a “best” case-based
PICO question, the next step is exploring
other searchable clinical queries.
P • These are a list of flexible alternative
questions since the answer to your precise
I C question may not match the current scientific
literature.
O
• Typically the alternatives involve reasonable
variations of your interventions/comparison
or alternative outcomes. (Cochrane, Lv 2012)
YOUR TURN!
For the next three cases, you will be divided up to
formulate the following:
• What are some background questions?
• What are your foreground PICO questions?
• Population
• "How would I describe a group of patients similar to mine?"
• Intervention/Comparison
• Ask “What is the main intervention I am considering?”
• and “What is the main comparison/control?”
• Outcomes
• Ask "What can I hope to accomplish?" or "What could this
exposure really affect?“
• Which outcomes are POEMs?
• Which outcomes are DOEs?
Case 1:
• A 35-year-old migrant farm worker presents
to your clinic for follow-up visit.
• A few weeks ago at a health fair, his blood
pressure was 170/98.
• Today on follow up, his vitals are
• T 98, P 88, R 16, BP 166/100, O2 99%
• You diagnose him with hypertension and look
at the 2014 JNC 8 guidelines to guide
medical treatment.
• He asks you: “Do I need medication, doctor?”
(JAMA; James, 2014)
Case 2:
• A 48-year-old Caucasian male construction worker
without any significant PMH sees you for a routine
physical exam.
• He reports that he is a two pack/day smoker for the
past 30+ years, and his father died of a heart attack
at age 49. He brings in a lab report of his cholesterol:
• Total cholesterol: 200, HDL: 40
• You use the Pooled Risk Cohort equation from the
2013 ACC/AHA Cholesterol Guidelines
• His 10-year risk to first ASCVD event is 7.7%.
• He asks you: Do I need a cholesterol medication
(statin)?
(Lancet; Ridker, 2013)
Case 3:
• A 55-year-old right-handed female executive
assistant presents to your clinic with numbness and
pain in both hands, primarily in the thumb and
index finger for the past year.
• She is worried now that she drops pens and paper more
easily.
• She wears a wrist splint at night and takes Naproxen
twice a day.
• She asks you about steroid injections that a co-
worker told her about and wants to know if this
could help her.
Answer?
Your challenge
• Medscape Evidence-
Structured
• eMedicine Based
Abstracts
Summaries
• Epocrates
• Lexicomp
Medical Literature
Appraise
Read
Apply
Question
Decide
Patient
Clinical Jazz = Traditional EBM + Shared Decision Making
(Structure) + (Improvisation)
(Shaughnessy, 1998)
Congratulations!
You are now able to:
• Explain the difference between foreground
and background questions
• Differentiate between patient-oriented
evidence and disease-oriented evidence
• Identify a foreground question and apply the
PICO format to create a searchable clinical
query
Resources